Table 4.
Alkaloid | Plant Source | Type of Cancer | Cell Lines (IC50/ED50) | Mechanism of Action | References |
---|---|---|---|---|---|
Oxymatrine | Sophora flavescens Ait. | breast | MCF7 | ↑Bax and ↓Bcl-2 | [82] |
ovarian | OVCAR-3 | Cleavage of caspase-3, ↑miR-29b and ↓matrix metalloproteinase-2 (MMP2) | [83] | ||
prostate | DU145, PC-3 | ↑Bax, ↑p53, and ↓Bcl-2 | [84] | ||
colorectal | RKO HCT116 SW480 |
Regulation of EMT markers (↑E-cadherin, ↓Snail and ↓N-cadherin) Inhibition of NF-κB activation, ↓p65 |
[85] | ||
lung | A549 | ↑Bax and ↓Bcl-2 | [86] | ||
gastric | MKN-45 BGC823 SGC7901 HEK293 |
G1 cell cycle arrest Disruption of mitochondrial membrane potential Inhibition of EGFR (p-Tyr845) ↓CyclinD1, ↓CDK4/6 ↑Bax and ↓Bcl-2 ↑ caspases-3 and -9 mRNA level ↓phospho-Cofilin (Ser3), phospho-LIMK1 (Thr508) levels, and ↓MMP2 |
[87] | ||
cervical | CaSki | G0/G1 and S cell cycle arrest ↓HPV16E7 |
[94] | ||
cervical | HeLa | ↓IMPDH2 ↓intracellular GTP |
[88] | ||
human hepatoma carcinoma | Hep-G2 (1.32 mg/mL) SMMC-7721 (1.21 mg/mL) |
↑Bax and ↓Bcl-2 and ↑caspase-3 mRNA level | [90] | ||
laryngeal squamous cell carcinoma | Hep-2 (7 mg/mL) | G0/G1 cell cycle arrest ↓HPV16E7 gene |
[91] | ||
Pancreatic | PANC-1 (1 mg/mL) | Inhibition of NF-κB activity, ↓VEGF | [89] | ||
osteosarcoma | MNNG/HOS (72.50 μg/mL) | ↑Bax and ↓Bcl-2 Disruption of mitochondrial membrane potential Efflux of cytochrome c Cleavage of caspases-3 and -9 Inactivation of PI3K/Akt pathway ↑Bax and ↓Bcl-2 |
[92] | ||
osteosarcoma | MG-63 (0.75 mg/mL) | Disruption of mitochondrial membrane potential Cleavage of caspases-3 and -9 ↑Bax and ↓Bcl-2 |
[116] | ||
hemangioma | HDEC | ↓HIF-1ɑ, ↓VEGF, ↑Bax and ↑p53, and ↓Bcl-2 G0/G1 cell cycle arrest and ↓cyclinD1 |
[93] | ||
breast | MCF-7 | ↓SP and ↓Wnt/β-catenin signaling pathways | [96] | ||
Piperine |
Piper nigrum L. Piper longum L. |
colon | CaCo-2 (54 μM) SW480 (126 μM) HCT116 (118 μM) HT-29 (53 μM) |
G1 cell cycle arrest Disruption of mitochondrial membrane potential Cleavage of caspases-3, -9 and PARP ↑ROS Induction of endoplasmic reticulum stress |
[98] |
triple-negative breast cancer | MDA-MB-468 T-47D MCF-7 |
Disruption of mitochondrial membrane potential Efflux of cytochrome c G1/S and G2/M cell cycle arrest Induction of caspase-dependent apoptosis ↓p-Akt, ↑p21Waf1/Cip1 ↓MMP-2/-9 mRNA levels |
[99] | ||
HER2-overexpressing breast cancer | SKBR3 (50 μM) BT-474 (50 μM) MCF-7 (200 μM) MDA-MB-231 |
Cleavage of caspase-3 and PARP ↓SREBP-1 and ↓FAS mRNA levels ↓HER2 Inhibition of Akt, MAPK, AP-1 and NF-κB activation Suppression of migration |
[104] | ||
osteosarcoma | HOS (72 μM) U2OS (126 μM) |
G2/M cell cycle arrest ↓cyclinB1, ↑p-CDK1, ↑p-Chk2 Inhibition of p-Akt Activation of c-JNK, p38MAPK- ↑TIMP-1/-2 and ↓MMP-2/-9 |
[100] | ||
prostate | DU145 (74.4 μM) PC-3 (226.6 μM) LNCaP (111 μM) |
G0/G1 cell cycle arrest Cleavage of caspase-3 Induction of autophagy via ↑LC3B-II and formation of LCb3 puncta ↑p21Cip1, ↑p27Kip1, ↓cyclin D1, ↓cyclin A |
[101] | ||
lung | A549 (122 μg/mL) | G2/M phase cell cycle arrest Cleavage of caspases-3 and -9 ↑Bax, ↑p53, and ↓Bcl-2 |
[102] | ||
rectal | HRT-18 | G0/G1cell cycle arrest ↑ROS |
[103] | ||
Piperlon-gumine | Piper longum L. | gastric | SGC-7901 (2.3 μM) BGC-823 (3.9 μM) KATO III: (6.0 μM) |
G2/M cell cycle arrest ↓MDM-2, ↓Cyclin B1, and ↓Cdc2 ↑ROS and ↓TrxR1 Cleavage of caspase-3 ↑Bax and ↓Bcl-2 Induction of ROS-dependent endoplasmic reticulum stress Induction of ROS-dependent mitochondrial dysfunction |
[113] |
head and neck | AMC-HN SNU HN30 HN31 |
↑ROS ↑p53, ↑PUMA, ↑p-JNK, ↓GSTP1 and ↑p21Waf1/Cip1 Cleavage of PARP |
[114] | ||
glioma | HGG 1123 HGG MD13 |
↑ROS levels ↓PRDX4 |
[107] | ||
large B cell lymphoma ABC-DLBCL |
OCI-Ly10 U2932 DB |
Inhibition of TNF-α and p65 nuclear import ↓NF-κB activity ↓survivin, Bcl-2, ↑Bax, nd ↑p21 Cleavage of caspases-3 and -9 |
[109] | ||
breast myeloid leukemia |
MCF7 (0.9 μM) MDA-MB-453 (0.9 μM) T-47D (2.7 μM), Kasumi-1 (3.7 μM) |
↓ p-STAT3 Inhibition of STAT3 binding to its immobilized phosphopeptide ligand Cleavage of caspase-3 ↑p53, ↓survivin, ↓Bcl-2, ↓Bcl-x, ↓XIAP, and ↓CIAP mRNA levels |
[108] | ||
gastric | AGS HGC27 |
↑ROS Cleavage of caspases-3, -7, -9 and PARP G2/M cell cycle arrest and ↑GADD45ɑ ↓CyclinB1, ↓cdc2, ↓XIAP, and ↑p21 ↓telomerase reverse transcriptase gene Induction of endoplasmic reticulum stress |
[106] | ||
renal carcinoma | 786-O PNX0010 (ED50: 1.6, 2.3 μM respectively) |
↓c-Met ↑ROS Inhibition of Erk/MAPK, STAT3, Akt/mTOR and NF-κB pathways |
[110] | ||
prostate | PC-3 DU-145 (ED50: 4.9, 3.4 μM respectively) |
Inhibition of TNF-α and p65 nuclear import Inhibition of NF-κB pathway ↓Il-6, ↓IL-8, ↓MMP-9 Inhibition surface expression of ICAM-1 |
[111] | ||
colon | HT-29 (10.1 μM) HCT 116 (6.4 μM) |
Cleavage of caspase-3 Induction of ERK signaling pathway via ↑p-ERK |
[112] |